Wednesday, September 16, 2009

FDA Defers Final Action On Milnacipran New Drug Application

Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) (the "Companies") announced that the U.S.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)